DJIA 16,880.36 -31.75 -0.19%
NASDAQ 4,462.90 20.20 0.45%
S&P 500 1,970.07 0.12 0.01%
market minute promo

24.45 0.08 (0.33%)

REAL-TIME: Last trade at

Extended Hours: $24.45 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

IDIX $24.45 0.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.39
Previous Close $24.37
Daily Range $24.37 - $24.45
52-Week Range $2.93 - $24.45
Market Cap $3.7B
P/E Ratio -26.49
Dividend (Yield) $0.00 (0.0%)
Volume 998,411
Average Daily Volume 2,186,086
Current FY EPS -$0.91

Sector

Healthcare

Industry

Drugs

Idenix Pharmaceuticals, Inc. (IDIX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe. Website: http://www.idenix.com/

News & Commentary Rss Feed

Gilead Sciences, Inc. Earnings: Will Sovaldi Send Shares Soaring?

Gilead has had huge stock gains over the past year, but earnings could come in flat from last year's levels. What's up with the big biotech company?

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog

Today In SA PRO: Monday, July 28

Announcing SA's First Outstanding Performance Award Winners

Stocks To Watch: Idenix, Cemex, GoPro...

Sector Update: Health Care Stocks Ending Mixed; Achillion Pharmaceutical Easing From M&A-Fueled Afte

Sector Update: Health Care Stocks Ending Mixed; Achillion Pharmaceutical Easing From M&A-Fueled Afternoon Rally

Sector Update: Health Care

A Pre-Earnings Update On Gilead

Seth Klarman Is Top-Performing Guru for First Half 2014

Seth Klarman Tops Guru Scoreboard for First Half 2014

Merck, Gilead Lead Race To Eradicate Hepatitis C

See More IDIX News...

IDIX's Top Competitors

IDIX $24.45 (0.33%)
Current stock: IDIX
AMGN $130.01 (5.43%)
Current stock: AMGN
GILD $93.79 (0.86%)
Current stock: GILD
BIIB $344.52 (0.82%)
Current stock: BIIB